hormone receptor-positive breast cancer
GPTKB entity
Statements (56)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:healthcare_organization
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:Verzenio
gptkb:Faslodex |
gptkbp:can_lead_to |
metastatic breast cancer
|
gptkbp:caused_by |
long-term hormone replacement therapy
|
gptkbp:has_style |
gptkb:estrogen_receptor-positive_breast_cancer
gptkb:progesterone_receptor-positive_breast_cancer |
gptkbp:hosts |
gptkb:tamoxifen
aromatase inhibitors |
https://www.w3.org/2000/01/rdf-schema#label |
hormone receptor-positive breast cancer
|
gptkbp:is_affected_by |
lifestyle factors
hormone levels |
gptkbp:is_associated_with |
obesity
psychosocial impacts increased risk of recurrence higher survival rates |
gptkbp:is_characterized_by |
the presence of hormone receptors
|
gptkbp:is_considered |
a significant health issue
a major subtype of breast cancer a subtype of invasive breast cancer |
gptkbp:is_evaluated_by |
oncologists
pathologists |
gptkbp:is_influenced_by |
genetic factors
|
gptkbp:is_linked_to |
support groups
hormonal imbalances alcohol consumption radiation exposure socioeconomic factors hormonal therapies patient education programs dietary factors physical inactivity family history of breast cancer age at first menstruation age at menopause |
gptkbp:is_monitored_by |
regular imaging tests
|
gptkbp:is_often_used_in |
postmenopausal women
African American women younger women |
gptkbp:is_part_of |
breast cancer awareness campaigns
breast cancer treatment guidelines breast cancer research initiatives breast cancer classification |
gptkbp:is_studied_in |
clinical trials
new treatment options |
gptkbp:is_subject_to |
research studies
|
gptkbp:occurs_in |
both men and women
|
gptkbp:recognizes |
mammography
|
gptkbp:requires |
gptkb:hospital
|
gptkbp:scientific_classification |
hormone-sensitive cancer
|
gptkbp:social_responsibility |
biopsy
|
gptkbp:treatment |
radiation therapy
chemotherapy targeted therapy hormonal therapy |